Thomas J. Knapp files SEC Form 4 disclosures for Sucampo Pharmaceuticals, Inc.. They have made 1 open-market trade across 1 company since 2015, most recently 2015-07-20.
CIK 0001311726
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SCMP | SELL | 2015-07-20 | 2015-07-22 | $23.43 | $1.5M | -21.8% | -3.5% | -3.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.